Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure

被引:47
作者
Zhang, Qing
Fung, Jeffrey Wing-Hong
Auricchio, Angelo
Chan, Joseph Yat-Sun
Kum, Leo C. C.
Wu, Li Wen
Yu, Cheuk-Man [1 ]
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Div Cardiol, Inst Vasc Med,SH Ho Cardiovasc & Stroke Ctr,Dept, Shatin, Hong Kong, Peoples R China
[2] Fdn Cardioctr Ticino, CH-6900 Lugano, Switzerland
关键词
cardiac resynchronization therapy; left ventricular mass; reverse remodelling; echocardiography;
D O I
10.1093/eurheartj/ehi885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims LV reverse remodelling has been shown to be a favourable response after cardiac resynchronization therapy (CRT) in many clinical trials. This study investigated whether left ventricular (LV) reverse remodelling after CRT has any structural benefit, which include the improvement of LV mass or regional wall thickness. Methods and results Fifty patients (66 +/- 11 years) receiving CRT were followed up for at least 3 months. Echocardiography with tissue Doppler imaging was performed serially before and at day 1 and 3 months after CRT Although LV end-systolic volume (LVESV) was decreased at day 1 after CRT (141 +/- 74 vs. 129 +/- 71 cm(3), P < 0.001), further LV reverse remodelling was observed at 3 months (110 +/- 67 cm(3), P < 0.001 vs. day 1). LV ejection fraction increased at day 1 (26.5 +/- 9.3 vs. 28.5 +/- 9.1%, P < 0.005) and was further improved at 3 months (34.2 +/- 10.5%, P < 0.001 vs. day 1). However, reduction of LV mass (231 +/- 67 vs. 213 +/- 59 g, P < 0.001) and regional wall thickness was only observed at 3 months, but not at day 1. The improvement of LV mass correlated with the change in LVESV (r = 0.66, P < 0.001) and the baseline systolic asynchrony index (Ts-SD) (r = -0.52, P < 0.001). LV mass was only decreased significantly in responders of UV reverse remodelling (245 +/- 66 vs. 207 +/- 61 g, P < 0.001), but increased in non-responders (209 +/- 64 vs. 223 +/- 56 g, P = 0.02). Responders had significant decrease in thickness of all the four walls for -6 to -11% (all P < 0.02), whereas non-responders had increased thickness in septal and lateral walls for +11% (both P < 0.05). Conclusion The acute reduction in LV volume after CRT is mediated by haemodynamic and geometric benefits without actual changes in LV mass. However, at 3-month follow-up, reduction in LV mass and regional wall thickness was demonstrated, which represents structural reverse remodelling. Such benefit was only observed in volumetric responders but was worsened in non-responders.
引用
收藏
页码:1423 / 1430
页数:8
相关论文
共 33 条
[1]   Cardiac resynchronization in chronic heart failure [J].
Abraham, WT ;
Fisher, WG ;
Smith, AL ;
Delurgio, DB ;
Leon, AR ;
Loh, E ;
Kocovic, DZ ;
Packer, M ;
Clavell, AL ;
Hayes, DL ;
Ellestad, M ;
Messenger, J ;
Trupp, RJ ;
Underwood, J ;
Pickering, F ;
Truex, C ;
McAtee, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) :1845-1853
[2]   Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay [J].
Auricchio, A ;
Stellbrink, C ;
Sack, S ;
Block, M ;
Vogt, J ;
Bakker, P ;
Huth, C ;
Schöndube, F ;
Wolfhard, U ;
Böcker, D ;
Krahnefeld, O ;
Kirkels, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) :2026-2033
[3]   Characterization of left ventricular activation in patients with heart failure and left bundle-branch block [J].
Auricchio, A ;
Fantoni, C ;
Regoli, F ;
Carbucicchio, C ;
Goette, A ;
Geller, C ;
Kloss, M ;
Klein, H .
CIRCULATION, 2004, 109 (09) :1133-1139
[4]   Cardiac resynchronization and death from progressive heart failure - A meta-analysis of randomized controlled trials [J].
Bradley, DJ ;
Bradley, EA ;
Baughman, KL ;
Berger, RD ;
Calkins, H ;
Goodman, SN ;
Kass, DA ;
Powe, NR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (06) :730-740
[5]   Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].
Bristow, MR ;
Gilbert, EM ;
Abraham, WT ;
Adams, KF ;
Fowler, MB ;
Hershberger, RE ;
Kubo, SH ;
Narahara, KA ;
Ingersoll, H ;
Krueger, S ;
Young, S ;
Shusterman, N .
CIRCULATION, 1996, 94 (11) :2807-2816
[6]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[7]   Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. [J].
Cazeau, S ;
Leclercq, C ;
Lavergne, T ;
Walker, S ;
Varma, C ;
Linde, C ;
Garrigue, S ;
Kappenberger, L ;
Haywood, GA ;
Santini, M ;
Bailleul, C ;
Daubert, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) :873-880
[8]  
CLELAND JG, 2005, NEW ENGL J MED, V352, P1594
[9]   Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease [J].
Doughty, RN ;
Whalley, GA ;
Gamble, G ;
MacMahon, S ;
Sharpe, N ;
Krum, H ;
Murray, Y ;
Tonkin, A ;
Trotter, A ;
Burton, R ;
Garrett, J ;
Lane, G ;
Watts, J ;
Geddes, C ;
Hall, C ;
Stephensen, J ;
Woodhouse, S ;
Davidson, T ;
Bradbury, J ;
Hamer, A ;
Hopkins, L ;
Jackson, D ;
Cross, D ;
Moreland, F ;
Hawtin, B ;
Kimber, V ;
Saunders, M ;
Thomson, A ;
Colquhoun, D ;
Goldsmith, J ;
Hicks, B ;
Bond, C ;
Flett, S ;
Murphy, J ;
Bruning, J ;
Jellyman, T ;
Nairn, L ;
Bartram, H ;
McCulloch, A ;
Milne, A ;
Prasad, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (05) :1060-1066
[10]   EFFECT OF METOPROLOL ON MYOCARDIAL-FUNCTION AND ENERGETICS IN PATIENTS WITH NONISCHEMIC DILATED CARDIOMYOPATHY - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
EICHHORN, EJ ;
HEESCH, CM ;
BARNETT, JH ;
ALVAREZ, LG ;
FASS, SM ;
GRAYBURN, PA ;
HATFIELD, BA ;
MARCOUX, LG ;
MALLOY, CR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (05) :1310-1320